Abstract
The cyclin-dependent kinase inhibitor p15INK4b has been shown to be involved in human and rodent tumors and seems to act as a tumor suppressor gene in hematological malignancies. Alterations of this gene in tumors include mainly homozygous deletions and hypermethylation of the CpG island in the promoter region. In this work, we describe a new area sensitive to methylation in the 3′ untranslated region (UTR) of the murine p15INK4b gene. This region shows different levels of methylation depending on the tissues, being relatively highly methylated in brain and gut, and weakly methylated in liver, spleen or thymus. DNA methylation and expression is similar in both maternal and paternal alleles indicating no imprinting effect. Although methylation of the p15INK4b 3′-UTR is low in normal thymus, increased levels (up to 100%) of specific methylation in this region are found in up to 30% of radiation- or carcinogen-induced thymic lymphomas, correlating with decreased gene expression. Hypermethylation of the p15INK4b 3′-UTR frequently occurs in tumors with loss of heterozygosity (LOH) but without methylation of the promoter CpG island or intragenic mutations. Furthermore, in vitro CpG methylation of the 3′-UTR produces reduced levels of a luciferase reporter in cultured cells. Methylation of two CpG sites in a 120 bp region is sufficient to interfere with transcription of the reporter gene. These data suggest that although the levels of p15INK4b in normal tissues can be mainly determined by promoter regulatory elements, strong hypermethylation of the 3′-UTR can interfere with transcription. Thus, hypermethylation of the 3′-UTR may explain the lack of p15INK4b gene expression in a subset of tumors with no promoter methylation and could be a new alternative mechanism for tumor suppressor gene inactivation in tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschmied J and Duschl J. . 1997 BioTechniques 23: 436–438.
Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL. . 1997 Cancer Res. 57: 832–836.
Battistuzzi G, D'Urso M, Toniolo D, Persico GM and Luzzatto L. . 1985 Proc. Natl. Acad. Sci. USA 82: 1465–1469.
Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. . 1998 Adv. Cancer Res. 72: 141–196.
Borrello MG, Pierotti MA, Tamborini E, Biassoni D, Rizzetti MG, Pilotti S and Della Porta G. . 1992 Oncogene 7: 269–275.
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky D. . 1995 Nat. Genet. 11: 210–212.
Cost GJ, Thompson JS, Reichard BA, Lee JY and Feinerg AP. . 1997 Cancer Res. 57: 926–929.
Glendeling JM, Flores JF, Walker GJ, Stone S, Albino AP and Fountain JW. . 1995 Cancer Res. 55: 5531–5535.
Graña X and Reddy EP. . 1995 Oncogene 11: 211–219.
Hannon GJ and Beach D. . 1994 Nature 371: 257–260.
Harper JW and Elledge SJ. . 1996 Curr. Opin. Genet. Dev. 6: 56–64.
Hatada I and Mukai T. . 1995 Nat. Genet. 11: 204–206.
Hengst L and Reed S. . 1996 Science 271: 1861–1864.
Herman JG, Jen J, Merlo A and Baylin SB. . 1996 Cancer Res. 56: 722–727.
Herman JG, Civin CI, Issa JPJ, Collector MI, Sharkis SJ and Baylin SB. . 1997 Cancer Res. 57: 837–841.
Hirama T and Koeffler HP. . 1995 Blood 86: 841–854.
Iavarone A and Massagué J. . 1997 Nature 387: 417–422.
Iguchi-Ariga SMM and Schaffner W. . 1989 Genes Dev. 3: 612–619.
Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B. . 1994 Cancer Res. 54: 6353–6358.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. . 1994 Science 264: 436–440.
Kay PH, Harmon D, Fletcher S, Ziman M, Jacobsen PF and Papadimitriou JM. . 1997 Gene 184: 45–53.
Laird PW and Jaenisch RJ. . 1996 Ann. Rev. Genet. 30: 441–464.
Li JM, Nichols MA, Chandrasekharan S, Xiong Y and Wang XF. . 1995 J. Biol. Chem. 270: 26750–26753.
Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B, Reichert U, Ordonez J and Fontana JA. . 1996 Cancer Res. 56: 5055–5062.
Lois AF, Cooper LT, Geng Y, Nobori T and Carson D. . 1995 Cancer Res. 55: 4010–4013.
Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A and Fernández-Piqueras J. . 1997 Oncogene 14: 1361–1370.
Malumbres M, Pérez de Castro I, Santos J, Pérez-Ollé R, Fernández-Piqueras J and Pellicer A. . 1998 Mamm. Genome 9: 183–185.
Matsuoka S, Thompson JS, Edwards MC, Barletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ and Feinberg AP. . 1996 Proc. Natl. Acad. Sci. USA 93: 3026–3030.
Meehan RR, Lewis JD and Bird AP. . 1992 Nucleic Acids Res. 20: 5085–5092.
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. . 1995 Nat. Med. 1: 686–692.
Mullins LJ, Veres G, Caskey CT and Chapman V. . 1987 Mol. Cell. Biol. 7: 3916–3922.
Nan X, Campoy FJ and Bird A. . 1997 Cell 88: 471–481.
Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M. . 1995 Science 269: 682–685.
Peters G. . 1994 Nature 371: 204–205.
Pollock PM, Pearson JV and Hayward NK. . 1996 Genes Chromosom. Cancer 15: 77–88.
Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter H, Walker C, Beach D, Sherr CJ and Serrano M. . 1995 Oncogene 11: 635–645.
Rasool O, Heyman M, Brandter LB, Liu Y, Grander D, Soderhall S and Einborn S. . 1995 Blood 85: 3431–3436.
Razin A and Cedar H. . 1991 Microbiol. Rev. 55: 451–458.
Reynisdóttir I and Massagué J. . 1997 Genes Dev. 11: 492–503.
Reynisdóttir I, Polyak K, Iavarone A and Massagué J. . 1995 Genes Dev. 9: 1831–1845.
Riggs AD. . 1975 Cytogenet. Cell Genet. 14: 9–25.
Riggs AD and Jones PA. . 1983 Adv. Cancer Res. 40: 1–30.
Rishi AK, Hsu CKA, Li XS, Hussain A, Gerald TM and Fontana JA. . 1997 Cancer Res. 57: 5129–5136.
Santos J, Pérez de Castro I, Herranz M, Pellicer A and Fernández-Piqueras J. . 1996 Oncogene 12: 669–676.
Savant-Bhonsale S and Cleveland DW. . 1992 Genes Dev. 6: 1927–1939.
Shandu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM and Stampfer MR. . 1997 Mol. Cell. Biol. 17: 2458–2467.
Sherr CJ. . 1996 Science 274: 1672–1677.
Sherr CJ and Robert JM. . 1995 Genes Dev. 9: 1149–1163.
Tsubari M, Tiihonen E and Laiho M. . 1997 Cancer Res. 57: 2966–2973.
Umezawa A, Yamamoto H, Rhodes K, Klemsz MJ, Maki RA and Oshima RG. . 1997 Mol. Cell. Biol. 17: 4885–4894.
Watt F and Molloy PL. . 1988 Genes Dev. 2: 1136–1143.
Zindy F, Quelle DE, Roussel MF and Sherr CJ. . 1997 Oncogene 15: 203–211.
Acknowledgements
We thank Dr Altschmied for providing the luciferase reporter vectors. This work was supported by NIH grants CA 36327 and CA 50434 to AP and grants from the Fundación Ramón Areces and DGES (PM96-001) to JF-P. MM received fellowships from the Fundación Ramón Areces and the MEC (Madrid, Spain). IPC was a fellowship of the Comunidad Autónoma de Madrid (Spain).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malumbres, M., Pérez de Castro, I., Santos, J. et al. Hypermethylation of the cell cycle inhibitor p15INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene 18, 385–396 (1999). https://doi.org/10.1038/sj.onc.1202299
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202299
Keywords
This article is cited by
-
Expression Profiling after Induction of Demethylation in MCF-7 Breast Cancer Cells Identifies Involvement of TNF-α Mediated Cancer Pathways
Molecules and Cells (2012)
-
Evidence for a new tumour suppressor gene locus for γ-radiation-induced thymic lymphoma located on the proximal part of mouse chromosome 18
Clinical and Translational Oncology (2004)
-
Gene expression profile favoring phenotypic reversion: a clue for mechanism of tumor suppression by NF-IL6 3′UTR
Cell Research (2003)
-
The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein–Barr virus-transformed lymphoblastoid cells
Genes & Immunity (2003)
-
Consistent inactivation of p19Arf but not p15Ink4b in murine myeloid cells transformed in vivo by deregulated c-Myc
Oncogene (2003)